Douglas Rodrigues is a consulting actuary with the Milwaukee office of Milliman. He joined the firm in 2014.
Douglas is a consulting actuary at Milliman with almost a decade of experience in the Medicare Advantage and pharmacy markets. He has assisted various medium-to-large health plans with Medicare Advantage and Part D bid development, desk review and bid audit support, strategic planning, market feasibility studies, risk sharing arrangements, risk score benchmarking and analytics, and analyzed the impact of various regulatory proposals and changes.
Specific to the pharmacy space, Douglas’ primary focus includes assisting health plans and employers with PBM audits, market checks, Request for Proposal evaluations, and ongoing support. Douglas is also a key contributor to the internal research supporting the Milliman prescription drug rating components of the Milliman Health Cost Guidelines (Rx HCGs), for both commercial and over-65 populations.
Presentations
Overview of the 2024 Notice, 4th Annual National MA Summit Conference by VMA Global Events, 15 April 2023 - By Philip Nelson and Douglas Rodrigues.
Medicare Advantage and Part D 101, MA Product Design & Management by Insight Exchange Network (IEN), 24 January 2019 - By Matt Chamblee, Julia Friedman, and Douglas Rodrigues.
Publications
Medicare Advantage: Strategies to increase plan revenue, 17 January 2020 - By Kelly Backes, Greg Herrle, and Douglas Rodrigues.
Medicare Advantage: Eight critical considerations for every organization as ESRD eligibility expands in 2021, 16 January 2020 - By Kelly Backes, Katherine Kroening, Douglas Rodrigues, and Gokce Yilmaz.
Government funding for Medicare Part D, 24 January 2019 - By Katherine Holcomb and Douglas Rodrigues.
Professional Designations
Education
Publications
